주메뉴 바로가기
서브메뉴 바로가기
본문 바로가기
About Us
CEO Greeting
Vision
History
CI
Location
Business
Business Outline
Vax-NK Platform
Vax-CARs Platform
Vaxleukin-15
R&D
Laboratory
Pipeline
Technology
IR
IR Resource
Public Disclosures
Public Disclosures
PR
Notice
News
Materials
Careers
Talents
Welfare
Recruitment
KOR
ENG
Goldmmune
TEL
menu open
VaxcellBio, Inc.
KOR
ENG
menu close
About Us
CEO Greeting
Vision
History
CI
Location
Business
Business Outline
Vax-NK Platform
Vax-CARs Platform
Vaxleukin-15 for Companion Animals
R&D
Laboratory
Pipeline
Technology
IR
Public Disclosures
Careers
Talents
Welfare
Recruitment
ⓒ VaxCell Biotherapeutics Co., Ltd.
PR
Notice
News
Materials
News
•
홈
> PR >
News
뉴스(한국경제) - 박셀바이오, 美 기업과 차세대 항암제 'ADC-NK' 개발 협약
관리자
2022. 03. 07. 12:43
ref.
2115
코리아 테라퓨틱스와 MOU
링크 :
https://www.hankyung.com/finance/article/202203078764i
Prev:
뉴스(이데일리) - 박셀바이오, 임상 2a상 연구에 2세대 NK 세포 치료제 적용
Next:
뉴스(아시아경제) - 박셀바이오, 고형암 CAR-T 치료제 특허 출원… AACR 발표도 예정
List